Status: Recruiting
Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs
The objective of this prospective observational study is to investigate the incidence of Medication Related Osteonecrosis of the Jaws (MRONJ) in patients receiving antiresorptive drugs for oncohematologic reasons during a 5-year follow-up. Secondary objectives are to compare the different antiresorptive drugs in relation to the incidence of MRONJ and to identify any systemic as well as local risk factors.
Participants needed: 126
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Catholic University of the Sacred HeartUpdated: Jun 20, 2024Locations: 1
Eligibility criteria
Patients with specific prescription to initiate therapy with antiresorptive drug...
Previous Head and Neck Radiotherapy